Orphan Medicinal Products and patient Advocacy Group

Orphan drugs are medicinal products that are used to treat rare diseases. They are called “orphan drugs” because due to their limited in market, only few pharmaceutical companies pursue research into such products. These drugs would not be produce without government assistance.

List of orphan medicinal products in Europe with European orphan designation

 

  • Adcetris
  • Adempas
  • Hetlioz
  • ChenodeoxycHolicAcidLeadiant
  • Besponsa
  • Iclusig
  • Ketoconazlehra
  • Namuscla
  • Roxon

Related Conference of Orphan Medicinal Products and patient Advocacy Group

May 18-19, 2026

15th World Congress on Rare Diseases and Orphan Drugs

Prague, Czech Republic
June 29-30, 2026

7th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
August 25-26, 2026

18th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands

Orphan Medicinal Products and patient Advocacy Group Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in